Core Scientific (CORZ) Cash from Investing Activities (2021 - 2026)
Core Scientific has reported Cash from Investing Activities over the past 6 years, most recently at -$386.7 million for Q1 2026.
- Quarterly results put Cash from Investing Activities at -$386.7 million for Q1 2026, down 334.36% from a year ago — trailing twelve months through Mar 2026 was -$1.0 billion (down 582.08% YoY), and the annual figure for FY2025 was -$740.8 million, down 678.16%.
- Cash from Investing Activities reached -$386.7 million in Q1 2026 per CORZ's latest filing, down from -$277.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $2.4 million in Q4 2023 and bottomed at -$386.7 million in Q1 2026.
- Median Cash from Investing Activities over the past 5 years was -$32.0 million (2024), compared with a mean of -$106.8 million.
- The largest annual shift saw Cash from Investing Activities surged 101.69% in 2023 before it tumbled 3656.53% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$139.5 million in 2022, then soared by 101.69% to $2.4 million in 2023, then plummeted by 1320.25% to -$28.8 million in 2024, then crashed by 864.54% to -$277.8 million in 2025, then tumbled by 39.2% to -$386.7 million in 2026.
- Business Quant data shows Cash from Investing Activities for CORZ at -$386.7 million in Q1 2026, -$277.8 million in Q4 2025, and -$254.4 million in Q3 2025.